Anshan Hifichem Co., Ltd. (SHE:300758)
China · Delayed Price · Currency is CNY 16.53
-0.55 (-3.22%)
Feb 13, 2026, 3:04 PM CST
Anshan Hifichem Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,508 | 1,543 | 1,198 | 1,159 | 1,319 | 999.26 |
Other Revenue | 24.71 | 24.71 | 20.28 | 49.47 | 27.56 | 9.05 |
| 1,533 | 1,568 | 1,218 | 1,209 | 1,347 | 1,008 | |
Revenue Growth (YoY) | 3.39% | 28.75% | 0.77% | -10.27% | 33.58% | 45.17% |
Cost of Revenue | 1,057 | 1,072 | 910.31 | 908.81 | 921.26 | 650.77 |
Gross Profit | 475.87 | 495.62 | 307.51 | 299.75 | 425.64 | 357.54 |
Selling, General & Admin | 209.16 | 202.71 | 180.5 | 189.91 | 137.62 | 86.52 |
Research & Development | 105.3 | 96.26 | 81.25 | 90.97 | 81.73 | 51.23 |
Other Operating Expenses | 12.29 | 8.76 | 9.21 | 11.41 | 10.8 | 8.23 |
Operating Expenses | 330.74 | 308.51 | 271.9 | 294.27 | 229.87 | 146.37 |
Operating Income | 145.13 | 187.1 | 35.61 | 5.47 | 195.77 | 211.16 |
Interest Expense | -45.72 | -38.67 | -35.9 | -29.88 | -15.92 | -10.84 |
Interest & Investment Income | 11.77 | 19.11 | 8.92 | 10.1 | 7.83 | 8.84 |
Currency Exchange Gain (Loss) | -1.57 | -1.57 | -0.12 | 8.18 | -2.42 | -5.08 |
Other Non Operating Income (Expenses) | 9.22 | 3.99 | -5.25 | -1.02 | 0.56 | -0.11 |
EBT Excluding Unusual Items | 118.83 | 169.97 | 3.26 | -7.14 | 185.82 | 203.96 |
Impairment of Goodwill | -6.34 | -6.34 | - | - | - | - |
Gain (Loss) on Sale of Investments | -17.35 | -12.33 | 2.13 | 2.99 | 13.35 | -0.41 |
Gain (Loss) on Sale of Assets | -0.49 | 0.16 | 0.32 | 0.05 | 5.02 | -1.11 |
Asset Writedown | -6.15 | -10 | -0.97 | -2.84 | -4.38 | -1.94 |
Legal Settlements | -0.91 | -0.91 | -1.88 | - | - | - |
Other Unusual Items | 0.83 | 6.68 | 5.27 | 3.41 | 8.33 | 10.68 |
Pretax Income | 88.42 | 147.22 | 8.13 | -3.54 | 220.92 | 211.18 |
Income Tax Expense | 5.58 | 15.68 | -8.96 | -14.83 | 20.68 | 25.66 |
Earnings From Continuing Operations | 82.83 | 131.54 | 17.09 | 11.29 | 200.24 | 185.52 |
Minority Interest in Earnings | -4.74 | -6.61 | -6.09 | -14.09 | -20.27 | -10.06 |
Net Income | 78.09 | 124.93 | 11 | -2.79 | 179.97 | 175.46 |
Net Income to Common | 78.09 | 124.93 | 11 | -2.79 | 179.97 | 175.46 |
Net Income Growth | -42.20% | 1035.48% | - | - | 2.57% | 62.31% |
Shares Outstanding (Basic) | 408 | 403 | 367 | 279 | 391 | 325 |
Shares Outstanding (Diluted) | 408 | 403 | 367 | 279 | 391 | 325 |
Shares Change (YoY) | 8.45% | 9.88% | 31.26% | -28.59% | 20.41% | 4.33% |
EPS (Basic) | 0.19 | 0.31 | 0.03 | -0.01 | 0.46 | 0.54 |
EPS (Diluted) | 0.19 | 0.31 | 0.03 | -0.01 | 0.46 | 0.54 |
EPS Growth | -46.71% | 933.33% | - | - | -14.82% | 55.57% |
Free Cash Flow | -96.89 | 57.58 | -163.59 | -99.43 | -0.63 | -140.74 |
Free Cash Flow Per Share | -0.24 | 0.14 | -0.45 | -0.36 | -0.00 | -0.43 |
Dividend Per Share | - | 0.050 | - | - | 0.700 | - |
Gross Margin | 31.04% | 31.61% | 25.25% | 24.80% | 31.60% | 35.46% |
Operating Margin | 9.47% | 11.93% | 2.92% | 0.45% | 14.54% | 20.94% |
Profit Margin | 5.09% | 7.97% | 0.90% | -0.23% | 13.36% | 17.40% |
Free Cash Flow Margin | -6.32% | 3.67% | -13.43% | -8.23% | -0.05% | -13.96% |
EBITDA | 289.11 | 328.1 | 172.63 | 126.35 | 279.56 | 267.43 |
EBITDA Margin | 18.86% | 20.93% | 14.18% | 10.46% | 20.76% | 26.52% |
D&A For EBITDA | 143.98 | 141 | 137.03 | 120.88 | 83.79 | 56.27 |
EBIT | 145.13 | 187.1 | 35.61 | 5.47 | 195.77 | 211.16 |
EBIT Margin | 9.47% | 11.93% | 2.92% | 0.45% | 14.54% | 20.94% |
Effective Tax Rate | 6.32% | 10.65% | - | - | 9.36% | 12.15% |
Revenue as Reported | 1,533 | 1,568 | 1,218 | 1,209 | 1,347 | 1,008 |
Advertising Expenses | - | 2.55 | 1.55 | - | - | 0.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.